Hospital Universitario Príncipe de Asturias

Madrid 28806

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Subjective Tinnitus

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus — Stopped early